These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12624743)

  • 21. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
    Hämmerle B; Elizalde C; Tejedor FJ
    Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
    Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
    Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain.
    Shim KS; Bergelson JM; Furuse M; Ovod V; Krude T; Lubec G
    J Neural Transm Suppl; 2003; (67):117-28. PubMed ID: 15068244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The brain in Down syndrome (TRISOMY 21).
    Lubec G; Engidawork E
    J Neurol; 2002 Oct; 249(10):1347-56. PubMed ID: 12382149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of phenotypic abnormalities of Down syndrome with an imbalance of genes on chromosome 21.
    Becker LE; Mito T; Takashima S; Onodera K; Friend WC
    APMIS Suppl; 1993; 40():57-70. PubMed ID: 8311992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice.
    Kazuki Y; Kimura M; Nishigaki R; Kai Y; Abe S; Okita C; Shirayoshi Y; Schulz TC; Tomizuka K; Hanaoka K; Inoue T; Oshimura M
    Biochem Biophys Res Commun; 2004 Apr; 317(2):491-9. PubMed ID: 15063784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
    Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
    Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human chromosome 21/Down syndrome gene function and pathway database.
    Nikolaienko O; Nguyen C; Crinc LS; Cios KJ; Gardiner K
    Gene; 2005 Dec; 364():90-8. PubMed ID: 16310977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using mouse models to explore genotype-phenotype relationship in Down syndrome.
    Salehi A; Faizi M; Belichenko PV; Mobley WC
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders.
    Kahlem P
    Behav Genet; 2006 May; 36(3):416-28. PubMed ID: 16557362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperation to amplify gene-dosage-imbalance effects.
    de la Luna S; Estivill X
    Trends Mol Med; 2006 Oct; 12(10):451-4. PubMed ID: 16919501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S100 protein and Down syndrome.
    Marks A; Allore R
    Bioessays; 1990 Aug; 12(8):381-3. PubMed ID: 2146955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass-spectrometrical analysis of proteins encoded on chromosome 21 in human fetal brain.
    Shin JH; Krapfenbauer K; Lubec G
    Amino Acids; 2006 Nov; 31(4):435-47. PubMed ID: 16622604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential interaction between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF transcription factor in Down syndrome-related Alzheimer disease.
    Banerjee D; Nandagopal K
    Cell Mol Neurobiol; 2007 Dec; 27(8):1117-26. PubMed ID: 17902044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical Region.
    Shin JH; Gulesserian T; Verger E; Delabar JM; Lubec G
    J Proteome Res; 2006 Jan; 5(1):44-53. PubMed ID: 16396494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
    Shim KS; Ferrando-Miguel R; Lubec G
    J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manifold decrease of sialic acid synthase in fetal Down syndrome brain.
    Gulesserian T; Engidawork E; Fountoulakis M; Lubec G
    Amino Acids; 2007 Jan; 32(1):141-4. PubMed ID: 16729195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray.
    Chung IH; Lee SH; Lee KW; Park SH; Cha KY; Kim NS; Yoo HS; Kim YS; Lee S
    J Korean Med Sci; 2005 Feb; 20(1):82-7. PubMed ID: 15716609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of carbonic anhydrase II in the developing Down syndrome brain.
    Palminiello S; Kida E; Kaur K; Walus M; Wisniewski KE; Wierzba-Bobrowicz T; Rabe A; Albertini G; Golabek AA
    Brain Res; 2008 Jan; 1190():193-205. PubMed ID: 18083150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.